RNA Interference

Latest News

Market of siRNAs Poised to Expand Beyond 3 Currently Approved Drugs
Market of siRNAs Poised to Expand Beyond 3 Currently Approved Drugs

February 25th 2021

While only 3 small interfering RNA (siRNA)-based therapies have been approved, the market is poised to expand with 7 other candidates in phase 3 trials.

Early Diagnosis May Lead to More Mild Disease Course for Patients With AHP
Early Diagnosis May Lead to More Mild Disease Course for Patients With AHP

February 19th 2021

Researchers Highlight Clinical Features of AHP, Emergence of siRNA-Based Therapies
Researchers Highlight Clinical Features of AHP, Emergence of siRNA-Based Therapies

February 18th 2021

Machine Learning May Help Diagnose Acute Hepatic Porphyria
Machine Learning May Help Diagnose Acute Hepatic Porphyria

January 29th 2021

Patients With Acute Hepatic Porphyria at Higher Risk of Accessing Long-term Sick Leave, Disability Pension
Patients With Acute Hepatic Porphyria at Higher Risk of Accessing Long-term Sick Leave, Disability Pension

January 28th 2021

More News

© 2023 MJH Life Sciences
AJMC®
All rights reserved.